checkAd

     225  0 Kommentare Basel, 11th June 2024   Medartis announces resignation of CEO Christoph Brönnimann

    Für Sie zusammengefasst
    • CEO Christoph Brönnimann resigns from Medartis
    • Successor search initiated by the Board
    • Medartis Chairman praises Brönnimann's leadership

    Medartis Holding AG / Key word(s): Personnel
    Basel, 11th June 2024   Medartis announces resignation of CEO Christoph Brönnimann

    11-Jun-2024 / 06:59 CET/CEST
    Release of an ad hoc announcement pursuant to Art. 53 LR
    The issuer is solely responsible for the content of this announcement.


    PRESS RELEASE

    Release of an ad hoc announcement pursuant to Art. 53 LR. The issuer is solely responsible for the content of this announcement.

    Medartis announces that its CEO, Christoph Brönnimann, has decided to resign from his position and leave the company to pursue other opportunities. Christoph will continue to lead Medartis until a successor is onboarded. He will remain focused on the execution of the company’s strategy and committed to a smooth transition to the new leadership. The Board has initiated a search for his successor and will announce an appointment in due course.

    Medartis Chairman, Marco Gadola, said: “Under Christoph’s leadership, Medartis has significantly accelerated its growth in its key markets, broadened the product portfolio and strengthened its standing with leading surgeons and hospitals worldwide. He has also expanded the capabilities of the organization and fostered an engaging culture, positioning the company for future success. This work will continue and growth remains our top priority.”

     

    Christoph added: “While this has been a difficult decision for me, I am proud of what we have accomplished together over the past five years. I will leave behind a talented executive team, a passionate organization and a company with huge potential for future growth.”

     

    The Board of Directors wholeheartedly thanks Christoph for his leadership, valuable contributions to Medartis and its success during his tenure, and wishes him all the best for his future endeavors.

     

    About Medartis
    Founded in 1997 and headquartered in Basel, Switzerland, Medartis (SIX Swiss Exchange: MED / ISIN CH0386200239) is one of the world's leading manufacturers and suppliers of medical devices for the surgical fixation of bone fractures in the upper and lower extremities and the craniomaxillofacial region. Medartis employs more than 830 people in 13 locations and its products are sold in more than 50 countries worldwide. Medartis is committed to providing surgeons and surgical staff with the most innovative titanium implants and instruments, as well as world-class service. For more information, please visit www.medartis.com.

    Contact:

    Medartis Holding AG
    Hochbergerstrasse 60E
    CH-4057 Basel

    Corporate Communications
    Investor contact: investor.relations@medartis.com
    Media contact: corporate.communication@medartis.com
    +41 61 633 37 36



    End of Inside Information
    Language: English
    Company: Medartis Holding AG
    Hochbergerstrasse 60E
    4057 Basel
    Switzerland
    Phone: +41 61 633 34 34
    Fax: +41 61 633 34 00
    E-mail: info@medartis.com
    Internet: www.medartis.com
    ISIN: CH0386200239
    Valor: 38620023
    Listed: SIX Swiss Exchange
    EQS News ID: 1921997

     
    End of Announcement EQS News Service

    1921997  11-Jun-2024 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1921997&application_name=news&site_id=wallstreet~~~257e03b8-9cbc-48b8-b6a5-ec526abf7b8e 


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    Basel, 11th June 2024   Medartis announces resignation of CEO Christoph Brönnimann Medartis Holding AG / Key word(s): Personnel Basel, 11th June 2024   Medartis announces resignation of CEO Christoph Brönnimann 11-Jun-2024 / 06:59 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible …